← Back to catalogue

Verdict®-Ii

FDA UDI

Class II (US FDA UDI)

by Medtox Diagnostics, Inc.

Identity

Trade Name
VERDICT®-II FDA UDI
Generic Name
Tricyclic antidepressant IVD, kit, rapid ICT, clinical FDA UDI
Device Name
A qualitative one-step immunochromatographic test for the detection of Tricyclic Antidepressants and/or metabolites in human urine. FDA UDI
Model / Reference
601629 FDA UDI
Description
A qualitative one-step immunochromatographic test for the detection of Tricyclic Antidepressants and/or metabolites in human urine. FDA UDI

Identifiers

Primary DI / UDI-DI
00690286000193 FDA UDI
510(k) Number
K002331 FDA UDI
K011545 FDA UDI
FDA Product Code
LFG FDA UDI
GMDN Term
Tricyclic antidepressant IVD, kit, rapid ICT, clinical FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
862.3910 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Tricyclic antidepressant IVD, kit, rapid ICT, clinical

Verdict®-Ii by Medtox Diagnostics, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Tricyclic antidepressant IVD, kit, rapid ICT, clinical.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 23f10063-9e89-48d3-adc9-212399b58402 36 fields · synced Jun 8, 2026